Get startedLog in
    Picture of Cue Biopharma logo

    CUE — Cue Biopharma News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeSmall CapNeutral
    All News

    Brief: Cue Biopharma Appoints New CEO, Shifts Focus to Autoimmune Therapies

    Picture of Cue Biopharma logoCue Biopharma
    29/09/2025 14:13
    Sept 29 (Reuters) - Cue Biopharma Inc CUE.O:

CUE BIOPHARMA ANNOUNCES STRATEGIC TRANSITION IN LEADERSHIP TO FURTHER ENABLE NEXT STAGE OF GROWTH WITH DISRUPTIVE AUTOIMMUNE THERAPEUTIC CANDIDATES

CUE BIOPHARMA INC - USMAN AZAM APPOINTED CEO OF CUE BIOPHARMA

CUE BIOPHARMA INC - DANIEL PASSERI TRANSITIONS TO STRATEGIC ADVISOR AT CO

Source text: ID:nGNX7tqC0T

Further company coverage: CUE.O

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Cue Biopharma

    See all news